09.02.2022 • NewsLonza

Lonza and HaemaLogiX Link on Cancer Drug

Lonza has agreed a manufacturing partnership with Australian biotech HaemaLogiX for the latter’s lead multiple myeloma drug candidate KappaMab.

Under the terms of the agreement, the Swiss CDMO will manufacture the drug’s active ingredient at its cGMP facility in Guangzhou, China. The target completion date for the finished drug product is the fourth quarter of 2022, when it will be used in Australian-based clinical trials.

KappaMab is a monoclonal antibody that binds to a cell surface target only found on myeloma cancer cells. This binding enables the immune system to respond and kill the myceloma cells, while sparing the healthy plasma cells. To date, KappaMab has been tested in three clinical trials. 

“Multiple myeloma is the second most common hematological cancer worldwide, with an estimated 32,000 new cases and over 12,500 deaths annually in the US alone (2019), and a European incidence roughly equivalent,” said HaemaLogiX chairman and CEO Bryce Carmine. “The incurable nature of multiple myeloma makes it necessary to expand treatment options available to patients. We look forward to taking KappaMab back into the clinic alongside standard of care, and this Lonza agreement is an important step toward providing the drug product for our upcoming trial.”

Last September, the Sydney-based biotech secured $10 million in new capital to advance the development of KappaMab.

Author: Elaine Burridge, Freelance Journalist

(c) LONZA
(c) LONZA

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.